Archives — December 2017 back to current month (61)

Copper Outlook at Critical Juncture and Implications for the Silver Price (12/30/2017)

Technical analyst Clive Maund delves into the reasons behind copper's recent rise and what that could mean for silver.

more>

When to Take Profits in the Cannabis Sector (12/28/2017)

With a run-up in cannabis stocks, technical analyst Clive Maund shares his thoughts on when investors should take profits.

more>

2017: A Year of Triple Digit Stock Performance (12/28/2017)

As stock indexes in the U.S. hit record highs in 2017, we take a look at some of the best performers profiled by Streetwise Reports in the last year, some of which have seen triple digit increases.

more>

Biotech's Shares 'Undervalued' and Positioned for 'Long-Term Upside Potential' (12/27/2017)

Zacks Small-Cap Research analyst John Vandermosten reviewed the Q2 FY18 financial results for this epigenetics firm, which is moving forward with a Phase 3 trial targeting heart disease.

more>

Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA (12/27/2017)

Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients undergoing heart surgery and will measure its effectiveness in reducing a common post-surgical side effect.

more>

Jack Chan's Weekly Precious Metals Market Update (12/27/2017)

Technical analyst Jack Chan charts the latest movements in the gold and silver markets, noting an upturn in the cycle that might indicate the end of a multimonth correction.

more>

Mining Project Financing Firm Transacts Royalty Agreement (12/27/2017)

BMO Capital Markets reported on this company's recent royalty transaction and its upside potential.

more>

Michael Ballanger: CME 'Fiat Police' Arrive Right on Schedule (12/27/2017)

Precious metals expert Michael Ballanger offers his take on how cryptocurrencies like Bitcoin can be affected by central banks.

more>

Gold Miner Seeks Approval to Boost Mill Capacity, 'Pumping Up the Potential' (12/27/2017)

Canaccord Genuity analyst Eric Zaunscherb discussed this precious metals company's recent request to the government of British Columbia.

more>

The Big Picture for Gold Is Bullish (12/26/2017)

Technical analyst Clive Maund charts gold and finds that although the precious metal is being buffeted by cross currents, the big picture is bullish.

more>

Silver Is a Strong Buy (12/26/2017)

An analysis of silver charts leads technical analyst Clive Maund to conclude that silver should rise soon.

more>

An Early-Stage Electric Vehicle Manufacturer in an Extremely High-Growth Market (12/22/2017)

Hunter Diamond, CFA, founder of Diamond Equity Research, profiles a company that he believes offers investors a unique opportunity to invest in the clean, renewable and sustainable transportation market.

more>

Bitcoin, Blockchain and Gold: A Year of Disruption (12/22/2017)

While gold is perceived to have lagged in 2017, the metal is actually up about 10% for the year, notes Frank Holmes, CEO of U.S. Global Investors. In this interview with The Gold Report, Holmes discusses bitcoin and blockchain's dramatic rise, the future of precious metals investing, and companies on his short list to watch.

more>

Four Miners Advance Exploration and Development Projects (12/22/2017)

Adrian Day of Adrian Day Asset Management takes a look at four companies, noting the progress made by three and reflecting on another that is "trying to salvage what it can of its best mine."

more>

A Set of Firms, Including Two Prospectors, Reviewed by Asset Manager (12/22/2017)

A pair of resource companies, along with another couplet of firms, prompted commentary from investment analyst Adrian Day of Adrian Day Asset Management.

more>

Prospector Picks First Exploration Target from New Acquisitions (12/21/2017)

Mike Niehuser, an analyst with Scarsdale Equities, provided background on an asset believed to be an "advanced exploration target."

more>

5 Undervalued Miners for This Tax-Loss Selling Season (12/21/2017)

As the year comes to a close, Ralph Aldis, portfolio manager of U.S. Global Investors, reviews some of his precious metals holdings and calls out a handful of companies he believes tax-loss selling has made particularly good values right now.

more>

Gold Miner Heading into the New Year with Results Above Expectations (12/21/2017)

With multiple gold exploration results coming in from its 100%-owned asset, this company is optimistic about its in-progress PEA on its Nevada property.

more>

'Exciting' Collaborations Possible for Biotech's 'Flexible' Platform (12/20/2017)

Zacks Small-Cap Research's John Vandermosten discussed the potential for this immunotherapy firm's RNAi compounds in oncology.

more>

Biotech Receives 'Major Endorsement from World-Leading Pharma Company' (12/20/2017)

David Kideckel, an analyst with Beacon Securities Ltd., relayed news from this firm's recent annual meeting, including a private placement with a large pharma and an update on the Phase 3 trial of its lead therapy.

more>

Updates from ASH Reinforce Analyst's Big Price Target Potential (12/20/2017)

Andrew Fein, an analyst with H.C. Wainwright & Co., discussed the implications of this biopharmaceutical's recently announced data, which support his "bullish" outlook for the firm's candidate in chronic graft versus host disease.

more>

Almaden Minerals Completes First-Ever Social Impact Assessment for Mexican Mining Project (12/20/2017)

The CEO of Almaden Minerals, Dr. Morgan Poliquin, sits down with Gerardo Del Real of Resource Stock Digest to discuss the company's Social Impact Assessment for its Ixtaca project in Mexico.

more>

A Pair of Gold Companies Log Changes, Make Progress (12/19/2017)

Adrian Day of Adrian Day Asset Management provides updates on two resource companies, one of which has "exciting recent reports." 

more>

The Bitcoin Market Would Like to Thank the Greatest Fool (12/18/2017)

With Bitcoin futures now trading on the CBOE, technical analyst Clive Maund expounds on why he believes the Bitcoin market is going to come crashing down.

more>

Tax Loss Silly Season Ending (12/18/2017)

With the year coming to an end and along with it the tax-loss selling season, Bob Moriarty of 321 Gold profiles five companies on his holiday list.

more>

Jack Chan's Weekly Precious Metals Market Update (12/18/2017)

Technical analyst Jack Chan charts the latest movements in the gold and silver markets, noting speculation has reached 'bull market values'.

more>

On the Brink of Legalization in California, Cannabis Company Stocks Should Soar (12/18/2017)

Technical analyst Clive Maund provides an argument for why two cannabis companies are poised for big gains following the legalization of recreational marijuana in the state of California.

more>

COT Report: Predictably Stomach Churning but Bullish (12/18/2017)

Precious metals expert Michael Ballanger explains why he finds gold stocks "dirt cheap."

more>

The Perfect Gold Stock for Revivalists (12/15/2017)

Technical analyst Clive Maund charts a young gold company that he believes "is going places."

more>

Cannabis Biotech Stock Starting to Advance Again (12/15/2017)

A technical analysis by Clive Maund on CliveMaund.com has a Buy on this cannabis biotech stock.

more>

New Uranium Assays Improve 'Resource Confidence' (12/14/2017)

David Talbot, an analyst with Eight Capital, outlined recent drill results from this energy company's flagship asset.

more>

Precious Metals Explorer to Acquire 'District-Scale Gold Properties' (12/14/2017)

Craig Stanley, an analyst with Eight Capital, took a look at the terms and potential of this mining company's prospective transactions in Ontario.

more>

Metallic Minerals Catches the Silver Ring (12/14/2017)

Silver is cheap right now, says Bob Moriarty of 321 Gold, who profiles a company in the Yukon that he says is delivering world-class exploration results.

more>

Micro-Cap Oil & Gas Explorer's First Permian Basin Well Flowing 465 Barrels/Day (12/13/2017)

Exploration is just beginning for this oil and gas E&P with large tracts of prime land in the Permian Basin in Texas.

more>

'The Market Gets it Wrong, Again'; Analyst Raises Target Price on Biotech (12/13/2017)

Ed Arce, an analyst with H.C. Wainwright & Co., explained the positive elements of this drug developer's recently released clinical trial data and why they did not warrant the market reaction they got.

more>

Bitcoin Total Wipeout Alert (12/13/2017)

Technical analyst Clive Maund discusses why he thinks Bitcoin is about to take a dive.

more>

Guyana Shield Is Host to Multiple Gold Deposits (12/12/2017)

As two Guyana projects begin commercial gold production, a new mineral resource estimate is in the works for a third project.

more>

Junior Miner Looking Good for Commercial Production in 2018, Analysts Say (12/12/2017)

A flagship Nevada project is showing results and the company anticipates commencing commercial production in the first quarter of 2018.

more>

Gold Major to Increase Dividend by 50% in 2018 (12/11/2017)

BMO Capital Markets reported on this miner's outlook for 2018 and beyond.

more>

Jack Chan's Weekly Precious Metals Market Update (12/11/2017)

Technical analyst Jack Chan charts the latest movements in the gold and silver markets.

more>

Cryptojunkies: Beware the Ides of December (12/11/2017)

As Bitcoin futures are set to begin trading next week, precious metals expert Michael Ballanger discusses movements in gold and cryptocurrencies.

more>

Keith Barron Wants to Mine U3O8 'Cheep' (12/11/2017)

More mining companies should follow the example of the garimpeiro miners of Brazil who mine until they fail to make a profit, says Bob Moriarty of 321 Gold, who discusses one gold and one uranium company that may be changing the paradigm.

more>

Positive Drill Results Confirm Large-Scale Potential for Nevada Lithium Project (12/10/2017)

Drill results from a Nevada lithium project caught the attention of The Critical Investor.

more>

Zinc Explorer Finally Hits at Zone 3; How Big Can the Resource Get? (12/09/2017)

The Critical Investor provides an update on this zinc explorer's latest drill results.

more>

A New Breed of Regenerative Therapy Companies Taking Hold (12/07/2017)

A regenerative therapy company with expertise in both cell therapy development and manufacturing, and a potential treatment for diabetes, differentiates this company, says Hunter Diamond, CFA, CEO of Diamond Equity Research.

more>

'Prospective Explorer' Working Toward Maiden Resource (12/07/2017)

Cormark Securities provided an update on this company's gold project in central Wyoming.

more>

Biotech Delivers 'Great' Phase 2 Data in NASH (12/07/2017)

John McCamant of the Medical Technology Stock Letter raised his target price on this company given the earning potential of a once-a-day oral treatment for liver disease in what could be a $35 billion market.

more>

Two 100%-Owned Projects Have Analysts Talking About a Possible 'JV Partnership Offer' (12/07/2017)

With an advanced project being looked at by potential partners and a newer project producing precious metal results, several analysts rate this precious metals explorer a "Buy."

more>

A Gold Explorer's Productive November Has Analysts Saying 'Buy' (12/07/2017)

Multiple projects are showing positive and possible expansions for this gold miner.

more>

Shining a Light on an Out-of-Favor Oil Stock (12/07/2017)

Technical analyst Clive Maund charts an oil and gas explorer that he believes is under the radar of most investors.

more>

Immuno-Oncology Candidate Yields 'Impressive' Early Clinical Results (12/06/2017)

This biotech reported positive results in a Phase 1b trial for its ovarian cancer immuno-oncology drug-delivery candidate, prompting increases in share price targets from a pair of analysts.

more>

Coverage Initiated on 'One of the Most Undervalued Biotech Companies in Canada' (12/06/2017)

David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm.

more>

Another Uranium Company to Slash Production in 2018 (12/05/2017)

A BMO Capital Markets report describes the implications of this cutback in production for the uranium market.

more>

Biotech Advances Potential 'Billion-Dollar Drug' with New Trial Launch in China (12/05/2017)

Maxim Group analyst Jason Kolbert discussed what the launch of a clinical trial in China means for this developer of immuno-oncology therapies.

more>

Will 2+2=8 For Columbus Gold? (12/05/2017)

Bob Moriarty of 321 Gold discusses why he believes a spinout could be a win for investors.

more>

Jack Chan's Weekly Precious Metals Report Also Charts Big Moves for Gold Major (12/04/2017)

Technical analyst Jack Chan charts the latest moves in the gold and silver markets, as well as the one-day fluctuations of a gold major.

more>

Drug in Combination with Merck's Blockbuster Keytruda Nearly Doubles Response Rate (12/04/2017)

Michael Sheikh, the founder of Falcon Strategic Research, delves into a biotech company whose trial results he believes could fuel takeover speculation.

more>

Agricultural Drone Nano-Cap Inks Deal with Monsanto Subsidiary (12/04/2017)

As farming becomes increasingly centralized, the need for precise agricultural data grows. Streetwise Reports spoke with Rick Mills, founder of Ahead of the Herd, and Fabrice Taylor, publisher of President's Club, on the fusion of drone-supplied data and data analytics.

more>

Explorer to Drill Flagship Copper Project with 'Blockbuster Discovery Hole' (12/01/2017)

Peter Epstein, founder of Epstein Research, evaluates Centenera Mining Corp.'s Esperanza copper-gold porphyry project.

more>

Silver and Gold Bottom Soon (12/01/2017)

Gold and silver are on track to hit a yearly low this December, as they have for the past five years, says Bob Moriarty of 321 Gold, who explains his reasoning and why he welcomes these moves.

more>

The True Meaning of Bitcoin's 'Success' (12/01/2017)

Precious metals expert Michael Ballanger discusses Bitcoin, currency devaluation, and gold and silver.

more>

More Archives

2018

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2013Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe